Harrington Discovery Institute Presents Live Webinar

Inside the Innovations Advancing COVID-19 Treatments

Harrington Discovery Institute at University Hospitals is hosting a webinar, “Inside the Innovations Advancing COVID-19 Treatments,” on October 28, 2021. Since its inception, Harrington Discovery Institute has helped develop nearly 150 new drugs at 61 institutions across the US, UK and Canada.

Moderated by Diana Wetmore, PhD, VP, Therapeutics Development, Harrington Discovery Institute, this live event will feature guest speaker Stephen K. Burley, MD, DPhil, Director, RCSB Protein Data Bank, Rutgers, The State University of New Jersey, four Harrington Scholars and their Harrington Advisors who are helping them advance their COVID-19 treatments into patients.

Featured Harrington Scholars

Anne Moscona, MD

Columbia University

Intranasal Agent to Block COVID-19 Infection

Joined by lead Harrington Advisor: Steve Brenner, PhD

Michel Nussenzweig, MD, PhD

The Rockefeller University

Human Antibodies to Prevent and Treat COVID-19

Joined by lead Harrington Advisor: Frank Richardson, PhD, DVM

James Reynolds, PhD

UH/CWRU

First Multipurpose Drug to Improve Lung and Heart Function in COVID-19 Patients

Joined by lead Harrington Advisor: Kaushik Dave, PhD, MBA, RPh

Joseph Vinetz, MD

Yale University

Antiviral Clinical Effects of Camostat Mesylate in Early COVID-19+ Outpatients

Joined by lead Harrington Advisor: Don Stanski, MD